A 
Arabian International Healthcare Holding Company SJSC 9530.SR · SAR
Health Care · Tadawul · 🇸🇦 Saudi Arabia
16.34
-3.88%
Close of 5 Nov 2026, in SAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in SAR, from our data supplier.
Revenue
SAR 842.2m
FY2019FY2025
Net income
SAR 23.8m
FY2019FY2025
Free cash flow
SAR 6.3m
FY2019FY2025
Shareholders' equity
SAR 365.2m
FY2019FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | SAR 842.2m | SAR 814.4m | SAR 806.9m | SAR 642.7m | SAR 618.5m | SAR 818.7m | SAR 697.0m |
| Gross profit | SAR 186.0m | SAR 180.0m | SAR 190.0m | SAR 154.2m | SAR 143.5m | SAR 198.4m | SAR 171.3m |
| Operating income | SAR 65.7m | SAR 29.2m | SAR 40.1m | SAR 60.6m | SAR 107.1m | SAR 142.5m | SAR 82.3m |
| Net income | SAR 23.8m | −SAR 66.6m | SAR 38.1m | SAR 20.5m | SAR 82.3m | SAR 95.8m | SAR 41.1m |
| Diluted earnings per share | 1.20 | -3.37 | 1.92 | 1.03 | 4.12 | 4.79 | 2.08 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total assets | SAR 1.33bn | SAR 1.35bn | SAR 1.40bn | SAR 1.41bn | SAR 1.03bn | SAR 1.31bn | SAR 1.34bn |
| Cash and short-term investments | SAR 4.9m | SAR 80.6m | SAR 82.4m | SAR 83.6m | SAR 11.0m | SAR 13.1m | SAR 14.2m |
| Total liabilities | SAR 967.4m | SAR 1.06bn | SAR 1.04bn | SAR 1.07bn | SAR 693.2m | SAR 976.8m | SAR 1.08bn |
| Debt | SAR 336.9m | SAR 493.9m | SAR 510.2m | SAR 470.4m | SAR 285.9m | SAR 337.7m | SAR 535.2m |
| Shareholders' equity | SAR 365.2m | SAR 244.0m | SAR 306.6m | SAR 289.7m | SAR 333.4m | SAR 332.4m | SAR 266.3m |
| Shares outstanding | 20m | 20m | 20m | 20m | 20m | 20m | 20m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | SAR 10.0m | SAR 105.7m | SAR 12.1m | SAR 60.2m | SAR 130.4m | SAR 222.8m | −SAR 22.1m |
| Capital spending | −SAR 3.7m | −SAR 3.4m | −SAR 7.9m | −SAR 6.4m | −SAR 4.0m | −SAR 1.4m | −SAR 2.3m |
| Free cash flow | SAR 6.3m | SAR 102.3m | SAR 4.2m | SAR 53.8m | SAR 126.4m | SAR 221.3m | −SAR 24.4m |
| Dividends paid | −SAR 12.3m | — | −SAR 19.8m | −SAR 60.0m | −SAR 82.7m | −SAR 30.9m | −SAR 16.9m |
Latest quarters
By quarter end
| Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Dec 2022 | Jun 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | SAR 493.4m | SAR 348.9m | SAR 540.3m | SAR 274.1m | SAR 491.0m | SAR 316.0m | SAR 427.4m | SAR 215.2m |
| Gross profit | SAR 115.3m | SAR 79.5m | SAR 125.3m | SAR 61.5m | SAR 121.3m | SAR 58.9m | SAR 113.4m | SAR 40.7m |
| Operating income | SAR 67.2m | −SAR 3.5m | SAR 45.7m | −SAR 36.7m | SAR 49.4m | −SAR 2.7m | SAR 66.6m | −SAR 13.0m |
| Net income | SAR 48.1m | −SAR 24.3m | −SAR 34.8m | −SAR 31.8m | SAR 60.9m | −SAR 22.8m | SAR 41.2m | −SAR 20.7m |
| Diluted earnings per share | 2.43 | -1.23 | -1.76 | -1.61 | 3.08 | -1.15 | 2.06 | -1.04 |
| Cash from operations | SAR 103.0m | −SAR 187.0m | SAR 127.0m | −SAR 17.0m | SAR 41.0m | −SAR 29.0m | SAR 139.0m | −SAR 76.0m |
| Capital spending | −SAR 2.0m | — | −SAR 2.0m | −SAR 1.0m | −SAR 2.0m | −SAR 5.0m | −SAR 2.0m | — |
| Free cash flow | SAR 101.0m | — | SAR 125.0m | −SAR 18.0m | SAR 39.0m | −SAR 34.0m | SAR 137.0m | — |
| Total assets | SAR 1.33bn | SAR 1.44bn | SAR 1.35bn | SAR 1.33bn | SAR 1.40bn | SAR 1.43bn | SAR 1.41bn | SAR 1.12bn |
| Cash and short-term investments | SAR 4.9m | SAR 98.7m | SAR 80.6m | SAR 75.8m | SAR 82.4m | SAR 85.8m | SAR 83.6m | SAR 20.9m |
| Debt | SAR 317.4m | SAR 479.0m | SAR 459.1m | SAR 495.6m | SAR 474.7m | SAR 498.3m | SAR 478.4m | SAR 292.1m |
| Shareholders' equity | SAR 365.2m | SAR 320.1m | SAR 244.0m | SAR 277.3m | SAR 306.6m | SAR 251.5m | SAR 289.7m | SAR 252.7m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 8.9% | 0.9% | — |
| Operating income | 2.7% | -14.4% | — |
| Net income | 5.1% | -24.3% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 22.1% | 22.9% | 23.2% | — |
| Operating margin | 5.7% | 6.3% | 9.8% | — |
| Net margin | -2.6% | 0.5% | 4.3% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Price to earnings | 18.7 | -11.9 | 20.7 | 36.2 |
| Price to sales | 0.6 | 1.0 | 1.0 | 1.2 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 19 Jun 2023.
| FY2023 | FY2022 | |
|---|---|---|
| Paid in the year | 1.00 | 3.00 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.